Abbott Can't Shake Roxane's Suit Over Generic Norvir

Law360, New York (June 21, 2012, 10:21 PM EDT) -- An Ohio federal judge on Thursday blocked Abbott Laboratories' bid to toss a suit by generic-drug maker Roxane Laboratories Inc. challenging two of Abbott's patents for its HIV drug Norvir in Roxane's effort to market generic versions of the drug.

U.S. District Judge Michael H. Watson rejected Abbott's bid to toss the suit or have it transferred to Delaware, finding Roxane had remained uncertain about the state of the two of patents covering Norvir ever since it filed an abbreviated new drug application with the U.S....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.